CC
Callan Capital Portfolio holdings
AUM
$1.35B
This Quarter Return
-7.26%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$614M
AUM Growth
+$614M
(-5.3%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
56.1%
Holding
131
New
19
Increased
51
Reduced
40
Closed
2
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 2.8% |
| 2 | Consumer Discretionary | 0.59% |
| 3 | Healthcare | 0.48% |
| 4 | Consumer Staples | 0.46% |
| 5 | Communication Services | 0.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$553M
| $202K | 0.03% |
3,908
+23
| +0.6% | +$1.19K |
|
127
Novo Nordisk
NVO
$251B
| $201K | 0.03% |
2,022
| – | – |
|
|
EFTR
128
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $11K | ﹤0.01% |
20,000
| – | – |
|
129
Philip Morris
PM
$261B
| – | – |
-2,126
| Closed | -$210K |
|
130
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.57B
| – | – |
-14,239
| Closed | -$259K |
|